|Minimum Order Quantity||50 Piece|
|Packaging Size||1 vial in a box with leaflet|
|Brand||Canmab 440 Inj.|
|Composition||Trastuzumab 440mg for inj.|
|Shelf life||2 Years|
Canmab Trastuzumab is one of a group of cancer drugs called monoclonal antibodies. Monoclonal antibodies are sometimes called targeted therapies because they work by targeting specific proteins (receptors) on the surface of cells. Some cancers have too much of a protein called human epidermal growth factor receptor 2 (HER2) on the surface of their cells. These are called HER2-positive cancers. The extra HER2 receptors stimulate the cancer cells to divide and grow. Trastuzumab locks on to the HER2 protein and blocks the receptor. This stops the cells from dividing and growing.
Canmab is a cancer medication that interferes with the growth and spread of cancer cells in the body. It is mainly used to treat certain types of breast cancer or stomach cancer.
Some side effects may occur during the injection. Speak your doctor right away if you feel dizzy, nauseated, light-headed, weak, short of breath, or if you have a headache, fever, chills, sudden chest pain, wheezing, dry cough, hives, or swelling of your face, lips, tongue, or throat.
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects.
Trastuzumab injection supplier from india, Trastuzumab injection Dealer in india, Trastuzumab injection supplier , Canmab injection supplier from india, Canmab injection supplier from india
|Minimum Order Quantity||500 Piece|
|Composition||Doxorubicin 10 MG injection Doxorubicin 50 MG injection|
|Usage||Hospital, Clinical, Personal|
|Minimum Order Quantity||25 Kg|
|Packaging size||25 KG|
|Treatment||Bortezomib is used for treating relapsed multiple myeloma and mantle cell lymphoma.|
|Shelf life||5 years if sealed and store away from direct sun light.|
|Storage||Stored in a clean,cool,dry area; keep away from moisture and strong,direct light/heat|
Bortezomib is used for treating relapsed multiple myeloma and mantle cell lymphoma.
Bortezomib interferes with the growth of cancer cells, which are then eventually destroyed by the body. Since the growth of normal body cells may also be affected by bortezomib, other effects will also occur. Some of these may be serious and must be reported to your doctor. Other effects, such as a skin rash, may not be serious but may cause concern. Some effects may not occur until months or years after the medicine is used.
1. Product: Bortezomib
2. CAS NO.: 179324-69-7
3. M.F.: C19H25BN4O4
4. M.W.: 384.2372
5. Appearance: white or almost white powder
6. Usage: to treat multiple myeloma